Unique ID issued by UMIN | UMIN000033473 |
---|---|
Receipt number | R000038170 |
Scientific Title | Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - an open label study |
Date of disclosure of the study information | 2019/01/01 |
Last modified on | 2019/07/05 21:19:08 |
Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - an open label study
Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - an open label study
Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - an open label study
Efficacy of sodium nitroprusside in the treatment of drug-naive subjects in first episode psychosis - an open label study
South America |
Regarding the design, this will be an open, non-randomized study.
Psychiatry |
Others
NO
To assess the efficacy of sodium nitroprusside administered as a single dose in the treatment of subjects in the first psychotic episode with no history of prior antipsychotic treatment
To assess the tolerability of sodium nitroprusside administered as a single dose in subjects in the first psychotic episode with no history of prior antipsychotic treatmen
Safety,Efficacy
Phase II
Evaluation of positive symptoms using the PANSS scale. Before the procedure and after 24 hours
Evaluation of negative symptoms, mania and general psychopathology, as well as side effects and tolerance. Using the PANSS and EACA-M scales.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
NO
NO
NO
1
Treatment
Medicine |
A single infusion session will be performed in which sodium nitroprusside will be used in continuous intravenous infusion under strict monitoring at a dose of 0.5 ug / kg / min for 240 minutes (04 hours). For administration, an infusion pump will be used and the medicament will be prepared and administered by a skilled practitioner in its use.
18 | years-old | <= |
60 | years-old | >= |
Male and Female
Patients of both sexes,
With first psychotic episode without previous treatment with antipsychotic.
Age between 18 and 60 years
Presence of relevant medical condition (cardiovascular diseases, neurological diseases, renal failure, liver disease, hypothyroidism, hyponatremia, hypovitaminosis B12, pregnancy, breastfeeding) or established and diagnosed organic frameworks.
History of hypersensitivity to sodium nitroprusside.
Diagnosis of substance abuse or dependence according to DSM-IV-TR criteria.
10
1st name | Marcelo |
Middle name | Pinheiro Machado |
Last name | Adelino |
Institute Bairral of Psychiatry
Sinapse Bairral Research Center
13970905
Hortencio Pereira da Silva 313 Itapira Brazil
551938639400
marceloadelino221@gmail.com
1st name | Marcelo |
Middle name | Pinheiro Machado |
Last name | Adelino |
Institute Bairral of Psychiatry
Sinapse Bairral Research Center
13970905
Hortencio Pereira da Silva 313 Itapira Brazil
551938639400
marceloadelino221@gmail.com
Sinapse Bairral Research Center
Sinapse Bairral Research Center
Self funding
Brazilian
Sinapse Bairral Research Center
Hortencio Pereira da Silva 313 Itapira Brazil
551938639400
marceloadelino221@gmail.com
NO
Institute Bairral of Psychiatry
2019 | Year | 01 | Month | 01 | Day |
Unpublished
Open public recruiting
2018 | Year | 05 | Month | 01 | Day |
2018 | Year | 08 | Month | 01 | Day |
2018 | Year | 09 | Month | 01 | Day |
2019 | Year | 01 | Month | 01 | Day |
2019 | Year | 02 | Month | 01 | Day |
2019 | Year | 02 | Month | 01 | Day |
2019 | Year | 02 | Month | 01 | Day |
2018 | Year | 07 | Month | 23 | Day |
2019 | Year | 07 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038170